NYMOX PHARMACEUTICAL CORPORATION Cash Flows From Used In Operating Activities
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Cash Flows From Used In Operating Activities of -$2.60 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:CashFlowsFromUsedInOperatingActivities · last filed 2025-06-03
- NYMOX PHARMACEUTICAL CORPORATION cash flows from used in operating activities for the quarter ending 2024-12-31 was -$717.00K.
- NYMOX PHARMACEUTICAL CORPORATION cash flows from used in operating activities for the quarter ending 2023-12-31 was -$897.00K.
- NYMOX PHARMACEUTICAL CORPORATION cash flows from used in operating activities for the quarter ending 2023-09-30 was -$1.26M.
- NYMOX PHARMACEUTICAL CORPORATION cash flows from used in operating activities for the quarter ending 2023-06-30 was -$909.00K, a 158.38% decline year-over-year.
| Period end | Cash Flows From Used In Operating Activities 3 month | Cash Flows From Used In Operating Activities 6 month | Cash Flows From Used In Operating Activities 9 month | Cash Flows From Used In Operating Activities 9 month as first filed | Cash Flows From Used In Operating Activities 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | -$717.00K derived: 20-F 12 month − 6-K 9 month · filed 2025-06-03 | -$2.60M 20-F · filed 2025-06-03 | |||
| 2024-09-30 | -$1.88M 6-K · filed 2025-01-02 | ||||
| 2023-12-31 | -$897.00K derived: 20-F 12 month − 6-K 9 month · filed 2025-06-03 | -$2.16M derived: sum of 2 quarters · filed 2025-06-03 | -$3.07M derived: sum of 3 quarters · filed 2025-06-03 | -$4.06M 20-F · filed 2025-06-03 | |
| 2023-09-30 | -$1.26M derived: 6-K 9 month − 6-K 6 month · filed 2025-01-02 | -$2.17M derived: sum of 2 quarters · filed 2025-01-02 | -$3.16M 6-K · filed 2025-01-02 | -$4.41M derived: sum of 4 quarters · filed 2025-06-03 | |
| 2023-06-30 | -$909.00K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-14 | -$1.90M 6-K · filed 2023-08-14 | -$3.15M derived: sum of 3 quarters · filed 2025-06-03 | -$4.45M derived: sum of 4 quarters · filed 2025-06-03 | |
| 2023-03-31 | -$988.00K 6-K · filed 2023-05-12 | -$2.24M derived: sum of 2 quarters · filed 2025-06-03 | -$3.54M derived: sum of 3 quarters · filed 2025-06-03 | -$1.99M derived: sum of 4 quarters · filed 2025-06-03 | |
| 2022-12-31 | -$1.25M derived: 20-F 12 month − 6-K 9 month · filed 2025-06-03 | -$2.56M derived: sum of 2 quarters · filed 2025-06-03 | -$998.00K derived: sum of 3 quarters · filed 2025-06-03 | -$5.21M 20-F · filed 2025-06-03 | |
| 2022-09-30 | -$1.31M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-15 | $251.00K derived: sum of 2 quarters · filed 2023-11-15 | -$3.96M 6-K · filed 2023-11-15 | -$6.21M derived: sum of 4 quarters · filed 2024-08-29 | |
| 2022-06-30 | $1.56M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-14 | -$2.65M 6-K · filed 2023-08-14 | -$4.90M derived: sum of 3 quarters · filed 2024-08-29 | -$7.90M derived: sum of 4 quarters · filed 2024-08-29 | |
| 2022-03-31 | -$4.21M 6-K · filed 2023-05-12 | -$6.46M derived: sum of 2 quarters · filed 2024-08-29 | -$9.46M derived: sum of 3 quarters · filed 2024-08-29 | -$11.36M derived: sum of 4 quarters · filed 2024-08-29 | |
| 2021-12-31 | -$2.25M derived: 20-F 12 month − 6-K/A 9 month · filed 2024-08-29 | -$5.25M derived: sum of 2 quarters · filed 2024-08-29 | -$7.15M derived: sum of 3 quarters · filed 2024-08-29 | -$9.82M 20-F · filed 2024-08-29 | |
| 2021-09-30 | -$3.00M derived: 6-K/A 9 month − 6-K 6 month · filed 2022-11-16 | -$4.90M derived: sum of 2 quarters · filed 2022-11-16 | -$7.57M 6-K/A · filed 2022-11-16 | $7.57M 6-K · filed 2021-11-12 | -$25.96M derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-06-30 | -$1.90M derived: 6-K 6 month − 6-K 3 month · filed 2022-08-15 | -$4.57M 6-K · filed 2022-08-15 | -$22.96M derived: sum of 3 quarters · filed 2023-05-02 | -$10.28M derived: sum of 4 quarters · filed 2023-05-02 | |
| 2021-03-31 | -$2.67M 6-K · filed 2022-05-13 | -$21.06M derived: sum of 2 quarters · filed 2023-05-02 | -$8.37M derived: sum of 3 quarters · filed 2023-05-02 | -$10.54M derived: sum of 4 quarters · filed 2023-05-02 | |
| 2020-12-31 | -$18.39M derived: 20-F 12 month − 6-K 9 month · filed 2023-05-02 | -$5.70M derived: sum of 2 quarters · filed 2023-05-02 | -$7.87M derived: sum of 3 quarters · filed 2023-05-02 | -$10.04M 20-F · filed 2023-05-02 | |
| 2020-09-30 | $12.69M derived: 6-K 9 month − 6-K 6 month · filed 2021-11-12 | $10.52M derived: sum of 2 quarters · filed 2021-11-12 | $8.35M 6-K · filed 2021-11-12 | -$8.35M 6-K · filed 2020-11-13 | $6.54M derived: sum of 4 quarters · filed 2022-03-30 |
| 2020-06-30 | -$2.16M derived: 6-K 6 month − 6-K 3 month · filed 2021-08-13 | -$4.33M 6-K · filed 2021-08-13 | -$6.15M derived: sum of 3 quarters · filed 2022-03-30 | -$8.04M derived: sum of 4 quarters · filed 2022-03-30 | |
| 2020-03-31 | -$2.17M 6-K · filed 2021-05-14 | -$3.98M derived: sum of 2 quarters · filed 2022-03-30 | -$5.87M derived: sum of 3 quarters · filed 2022-03-30 | -$8.01M derived: sum of 4 quarters · filed 2022-03-30 | |
| 2019-12-31 | -$1.81M derived: 20-F 12 month − 6-K 9 month · filed 2022-03-30 | -$3.71M derived: sum of 2 quarters · filed 2022-03-30 | -$5.84M derived: sum of 3 quarters · filed 2022-03-30 | -$7.43M 20-F · filed 2022-03-30 | |
| 2019-09-30 | -$1.89M derived: 6-K 9 month − 6-K 6 month · filed 2020-11-13 | -$4.02M derived: sum of 2 quarters · filed 2020-11-13 | -$5.62M 6-K · filed 2020-11-13 | -$7.30M derived: sum of 4 quarters · filed 2021-03-29 | |
| 2019-06-30 | -$2.13M derived: 6-K 6 month − 6-K 3 month · filed 2020-08-14 | -$3.73M 6-K · filed 2020-08-14 | -$5.41M derived: sum of 3 quarters · filed 2021-03-29 | -$7.78M derived: sum of 4 quarters · filed 2021-03-29 | |
| 2019-03-31 | -$1.59M 6-K · filed 2020-05-14 | -$3.28M derived: sum of 2 quarters · filed 2021-03-29 | -$5.65M derived: sum of 3 quarters · filed 2021-03-29 | -$7.56M derived: sum of 4 quarters · filed 2021-03-29 | |
| 2018-12-31 | -$1.69M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-29 | -$4.06M derived: sum of 2 quarters · filed 2021-03-29 | -$5.97M derived: sum of 3 quarters · filed 2021-03-29 | -$7.80M 20-F · filed 2021-03-29 | |
| 2018-09-30 | -$2.37M derived: 6-K 9 month − 6-K 6 month · filed 2019-11-13 | -$4.28M derived: sum of 2 quarters · filed 2019-11-13 | -$6.11M 6-K · filed 2019-11-13 | -$7.38M derived: sum of 4 quarters · filed 2020-03-30 | |
| 2018-06-30 | -$1.91M derived: 6-K 6 month − 6-K 3 month · filed 2019-08-14 | -$3.74M 6-K · filed 2019-08-14 | -$5.01M derived: sum of 3 quarters · filed 2020-03-30 | -$7.44M derived: sum of 4 quarters · filed 2020-03-30 | |
| 2018-03-31 | -$1.83M 6-K · filed 2019-05-15 | -$3.10M derived: sum of 2 quarters · filed 2020-03-30 | -$5.53M derived: sum of 3 quarters · filed 2020-03-30 | -$7.30M derived: sum of 4 quarters · filed 2020-03-30 | |
| 2017-12-31 | -$1.27M derived: 20-F 12 month − 6-K 9 month · filed 2020-03-30 | -$3.70M derived: sum of 2 quarters · filed 2020-03-30 | -$5.47M derived: sum of 3 quarters · filed 2020-03-30 | -$6.21M 20-F · filed 2020-03-30 | |
| 2017-09-30 | -$2.43M derived: 6-K 9 month − 6-K 6 month · filed 2018-11-13 | -$4.20M derived: sum of 2 quarters · filed 2018-11-13 | -$4.94M 6-K · filed 2018-11-13 | ||
| 2017-06-30 | -$1.77M derived: 6-K 6 month − 6-K 3 month · filed 2018-08-13 | -$2.51M 6-K · filed 2018-08-13 | |||
| 2017-03-31 | -$740.00K 6-K · filed 2018-05-15 | ||||
| 2016-12-31 | -$4.50M 20-F · filed 2019-03-29 | ||||
| 2015-12-31 | -$3.75M 20-F · filed 2018-03-30 |